These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin. Rodriguez JC; Garcia-Pachon E; Flores E; Escribano I; Ruiz M; Royo G J Chemother; 2007 Oct; 19(5):599-601. PubMed ID: 18073162 [No Abstract] [Full Text] [Related]
5. Synthesis and antimycobacterial activity of some heteroarylcarboxamidrazone derivatives. Billington DC; Coleman MD; Ibiabuo J; Lambert PA; Rathbone DL; Tims KJ Drug Des Discov; 1998 Oct; 15(4):269-75. PubMed ID: 10546071 [TBL] [Abstract][Full Text] [Related]
6. Kanamycin and neomycin resistance in Mycobacterium ranae (fortuitum) associated with serological and biochemical markers. Grange JM; Nordstrom G Zentralbl Bakteriol Orig A; 1974 Mar; 226(3):369-75. PubMed ID: 4151730 [No Abstract] [Full Text] [Related]
7. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum. Bardouniotis E; Ceri H; Olson ME Curr Microbiol; 2003 Jan; 46(1):28-32. PubMed ID: 12432460 [TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of Mycobacterium fortuitum by the broth microdilution method determining the inhibitory minimal concentration]. Ferrá Salazar C; Ramírez Alvarez MM; Montoro Cardoso E; Jiménez Misas CA; Fundora M Rev Cubana Med Trop; 1992; 44(2):109-12. PubMed ID: 9768199 [TBL] [Abstract][Full Text] [Related]
9. Genetic studies on the development of resistance to neomycin and dihydrostreptomycin in Mycobacterium ranae. HSIE JW; BRYSON V Trans Annu Meet Natl Tuberc Assoc; 1950; 46():97-115. PubMed ID: 14788197 [No Abstract] [Full Text] [Related]
10. Activity of various drugs alone or in combination against Mycobacterium fortuitum. Santos A; Cremades R; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G J Infect Chemother; 2010 Feb; 16(1):64-7. PubMed ID: 20063030 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Susceptibility Testing and Molecular Characterization of Mycobacterium fortuitum Isolates in China. Zheng HW; Pang Y; He GX; Song YY; Zhao YL Biomed Environ Sci; 2017 May; 30(5):376-379. PubMed ID: 28549494 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin). Tsukamura M Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156 [No Abstract] [Full Text] [Related]
14. [Studies on Mycobacteria. 5. Effect of body fluids from patients treated with antibiotics on human Mycobacterium tuberculosis]. SPANEDDA A G Batteriol Immunol; 1953; 45(7-8):304-15. PubMed ID: 13095751 [No Abstract] [Full Text] [Related]
15. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives. Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of some beta-lactams in combination with dicloxacillin against Mycobacterium fortuitum. Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Oratore A; Orefici G J Chemother; 1989 Jul; 1(4 Suppl):339-41. PubMed ID: 16312429 [No Abstract] [Full Text] [Related]
17. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays. Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065 [TBL] [Abstract][Full Text] [Related]
18. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria. McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787 [TBL] [Abstract][Full Text] [Related]
19. The influence of various sources of nitrogen on the activity of antimicrobial drugs. II. Mycobacterium avium. WEINBERG ED Am Rev Tuberc; 1953 Apr; 67(4):503-8. PubMed ID: 13031067 [No Abstract] [Full Text] [Related]
20. Effects of glutathione and N-acetyl cysteine on the antimycobacterial efficacy of isoniazid on Mycobacterium fortuitum in vitro. Coleman MD; Aerry R; Wanogho E; Khan NB; Lambert PA; Rathbone DL J Chemother; 2006 Dec; 18(6):665-6. PubMed ID: 17267348 [No Abstract] [Full Text] [Related] [Next] [New Search]